Shenzhen Bioeasy Biotechnology Co., Ltd.

Shenzhen Stock Exchange 300942.SZ

Shenzhen Bioeasy Biotechnology Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 84.76 M

Shenzhen Bioeasy Biotechnology Co., Ltd. Cash and Short-Term Investments is USD 84.76 M for the year ending December 31, 2023, a 136.38% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 35.86 M, a -66.61% change year over year.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 107.40 M, a 84.92% change year over year.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 58.08 M, a -8.55% change year over year.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 63.51 M, a 130.69% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
Shenzhen Stock Exchange: 300942.SZ

Shenzhen Bioeasy Biotechnology Co., Ltd.

CEO Mr. Zhaoli Xiao
IPO Date Feb. 9, 2021
Location China
Headquarters Room 101, Yirui Biological Building
Employees 389
Sector Consumers Staples
Industries
Description

Shenzhen Bioeasy Biotechnology Co., Ltd. develops and sells rapid testing instruments and reagents in China. The company offers detection equipment for use in the fields of food, agricultural, dairy, meat, aquatic, honey, drug, and public safety, as well as clinical diagnosis. Shenzhen Bioeasy Biotechnology Co., Ltd. was founded in 2007 and is based in Shenzhen, China.

StockViz Staff

February 2, 2025

Any question? Send us an email